Increlex and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Increlex (mecasermin recombinant), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Nutropin, and have Body height below normal.

The phase IV clinical study analyzes which people have Drowsiness when taking Increlex. It is created by eHealthMe based on reports of 1,007 people who have side effects when taking Increlex from the FDA, and is updated regularly.

What is Increlex?

Increlex has active ingredients of mecasermin recombinant. eHealthMe is studying from 1,010 Increlex users. Check the latest studies of Increlex.

What is Drowsiness?

Drowsiness is found to be associated with 2,871 drugs and 4,770 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Dec, 17, 2025

1,007 people reported to have side effects when taking Increlex.
Among them, 24 people (2.38%) have Drowsiness.

Among these 24 people:

How long have people been on Increlex when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Increlex? *

female: 50 %
male: 50 %

What is the age of people who have Drowsiness when taking Increlex? *

What are other drugs people take besides Increlex? *

What are other side effects people have besides Drowsiness? *

Hypoglycemia (low blood sugar): 6 people, 25.00%
Headache (pain in head): 6 people, 25.00%
Depression: 4 people, 16.67%
Nausea And Vomiting: 3 people, 12.50%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 12.50%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 3 people, 12.50%
Blood Glucose Decreased: 3 people, 12.50%
Blood Glucose Increased: 3 people, 12.50%
Fatigue (feeling of tiredness): 3 people, 12.50%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 8.33%

What are the existing conditions these people have? *

Body Height Below Normal: 6 people, 25.00%
Insulin-Like Growth Factor Decreased: 4 people, 16.67%
Growth Retardation (delayed growth): 2 people, 8.33%
Stress And Anxiety: 1 person, 4.17%
Otitis (ear infection): 1 person, 4.17%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 4.17%
Failure To Thrive (inadequate weight gain and physical growth in children): 1 person, 4.17%
Depression: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Increlex and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Increlex:

Increlex (1,010 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Increlex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,871 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,770 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mecasermin recombinant (the active ingredients of Increlex) and Increlex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.